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Abstract: Escherichia coli O157:H7 is an important food-borne pathogen and cause of hemorrhagic colitis
and hemolytic uremic syndrome in humans. Cattle are an important reservoir of E. coli O157:H7, in which
the organism colonizes the intestinal tract and is shed in the feces. Vaccination of cattle has significant potential as a pre-harvest intervention strategy for E. coli O157:H7; however, basic information about the bovine
immune responses to important bacterial colonization factors resulting from infection has not been reported.
The serum and fecal IgG and IgA antibody responses of adult cattle to E. coli O157:H7 intimin, translocated
intimin receptor (Tir), E. coli-secreted proteins (Esp)A, EspB and O157 lipopolysaccharide (LPS) in response
to infection were determined. All animals were seropositive for all five antigens prior to inoculation, with antibody titers to EspB and O157 LPS significantly higher (P < 0.05) than those to Tir, intimin and EspA. After
inoculation, the cattle became colonized and developed significant increases in their serum antibody titers to
intimin, Tir, EspB, EspA and O157 LPS (P < 0.05); however, by 42 days post-inoculation the titers to all except EspB were on the decline. In contrast, pre- and post-inoculation fecal IgG and IgA antibodies to these
same antigens were not detected (<1:5). These results indicate that cattle respond serologically to E. coli
O157:H7 type III secreted proteins, intimin and O157 LPS during the course of infection and the response is
correlated with the extent of fecal shedding.
Keywords: Escherichia coli O157:H7, Cattle, Type III secreted proteins, Locus of enterocyte effacement, Antibodies, Humoral immunity

low et al., 2006]). Cattle are an asymptomatic reservoir of this microorganism; their fecal material is an
important source of food and water contamination,
and means of spread to humans through direct contact (Renter and Sargeant, 2002).
E. coli O157:H7 expresses an outer membrane protein known as intimin (Eae) and several type III secreted proteins that are involved in the induction of
A/E lesions in the intestinal epithelium. Some of the
more well-characterized type III secreted proteins include the translocated intimin receptor (Tir) and the

1. INTRODUCTION
Escherichia coli O157:H7 is an important food-borne,
zoonotic pathogen that causes hemorrhagic colitis and
hemolytic uremic syndrome (HUS) in humans (Bell,
2002). It is the prototype of the enterohemorrhagic E.
coli (EHEC) class, all of which produce Shiga toxin
(Stx) and cause attaching–effacing (A/E) lesions (Law,
2000). In the United States, ground beef is the most
common vehicle associated with food-borne outbreaks
of E. coli O157:H7 ([Caprioli et al., 2005] and [Bar229
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E. coli-secreted proteins [Esp] A and B (Hartland et
al., 2000). Proteins involved in the induction of A/E lesions are encoded by genes on a chromosomal pathogenicity island known as the locus of enterocyte effacement (LEE) (Frankel et al., 1998). Tir, EspB and
other LEE-encoded type III secreted effector proteins
are delivered into the host cell through a transiently
produced filamentous translocation tube (Nougayrede
et al., 2003), which consists of an assembly of EspA
subunits (Frankel et al., 1998). These effectors cause
a series of cytoskeletal alterations resulting in effacement of the microvilli and pedestal formation at the
site of bacterial attachment (Roe et al., 2003). Tir,
which has become integrated into the host cell membrane, is bound to intimin, and this event mediates
intimate attachment of the bacterium to the host cell
(DeVinney et al., 1999).
Intimate attachment of bacteria to mucosal epithelial cells significantly enhances intestinal colonization
in cattle and other species. The induction of A/E lesions in colonic and rectal (Baehler and Moxley, 2000)
and ileal (Phillips et al., 2000) epithelial cells of adult
cattle by E. coli O157:H7 was first demonstrated using
mucosal explants (in vitro organ cultures). Later, these
lesions were demonstrated in vivo in adult cattle with
the further identification of the terminal rectum as a
major site of colonization (Naylor et al., 2005). Further conclusive evidence of the importance of A/E lesion formation in colonization has been based on studies with LEE gene deletion mutants. Deletion of eae or
the LEE4 operon caused a significant reduction in enteritis and bacterial fecal shedding in experimentally
infected calves ([Dean-Nystrom et al., 1998] and [Naylor et al., 2005]). Similarly, deletion of eae resulted in
reduced colonization and fecal shedding in experimentally infected yearling cattle (Cornick et al., 2002).
Human patients with HUS caused by E. coli O157:
H7 infection have robust serum antibody responses to
Tir ([Li et al., 2000] and [Yoh et al., 2003]). Based on
this observation, the hypothesis was raised that type
III secreted proteins would be a suitable vaccine target for this pathogen in humans and cattle (Li et al.,
2000). Subsequent studies demonstrated that a vaccine prepared from culture supernatant materials enriched with LEE-encoded type III secreted proteins
has significant potential as a pre-harvest intervention
strategy for E. coli O157:H7 in cattle (Potter et al.,
2004). Experimental challenge of calves with an E.
coli O157:H7 strain containing a deletion of the LEE4
operon also provided proof-of-concept for the utilization of type III secreted proteins as a vaccine strategy
(Naylor et al., 2005).
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Some studies have not found vaccination to be efficacious. One was a large-scale clinical trial in feedlot cattle which utilized type III secreted proteins as
the vaccine antigen. In that study, the proteins were
treated with formalin, which may have altered their
immunogenicity (van Donkersgoed et al., 2005). In
another study, young calves vaccinated with different
EHEC antigens developed humoral and salivary IgA
responses, but were not protected against intestinal
colonization by E. coli O157:H7 following experimental challenge (van Diemen et al., 2007).
Although vaccination of cattle is being actively
pursued as an intervention strategy for E. coli O157:
H7, little is known about the bovine immune responses to important bacterial colonization factors resulting from infection. Many of these factors could potentially serve as immunogens, but no information is
available about the effects of infection in this regard,
which may serve as a priming exposure to the respective antigen. Further, very few studies have been conducted in slaughter-age (adult yearling) cattle, which
are the most relevant model, since these animals are
the main source of ground beef for human consumption. The primary objective of this study was to determine whether adult cattle develop significant serum
and fecal antibody responses to LEE-encoded proteins
in response to infection with E. coli O157:H7.
2. MATERIALS AND METHODS
2.1. Experimental animals
Thirty healthy crossbred yearling beef cattle (~16
months old, mean weight, 447.7 ± 86.0 kg) were obtained from the University of Nebraska-Lincoln
(UNL) herd at Ithaca, NE. Prior to beginning the
study, the cattle were prophylactically treated with
topical ivermectin pour-on (0.5 mg/kg BW; ProMectin B, Vedco, St. Joseph, MO) and oral sulfamethazine boluses (350 mg/kg BW; Sustain III, Bimeda,
Inc., Le Sueur, MN). The week immediately prior to
inclusion into the study, each animal tested negative for coccidia and nematodes by fecal flotation technique and ectoparasites by clinical examination. Each
animal also was negative for Salmonella spp. and E.
coli O157:H7 in three successive fecal cultures over a
1-week period, using standard enrichment and plating methods ([Smith et al., 2001] and [Smith et al.,
2005]), and negative for bovine viral diarrhea virus
by antigen capture ELISA conducted on sera. Following the health screen, the cattle (n = 30) were tested
by indirect ELISA for pre-existing serum IgG and
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IgA antibodies to E. coli O157:H7 intimin, Tir, EspA,
EspB and O157 LPS, as described below. Thereafter,
six of these animals, chosen at random, were transported to and individually housed in biosafety level
(BL)-2 containment rooms. One week prior to use,
BL-2 isolation rooms were disinfected by fumigation
with paraformaldehyde. Cattle were fed once daily
with a nutritionally balanced ration without antibiotics (UNL Beef Feed 51786AAA, Consolidated Nutrition, Omaha, NE) and water was available ad libitum. Cattle were acclimated to the rooms and diet
prior to inoculation.
2.2. BL-2 animal isolation rooms
BL-2 animal isolation rooms had individual floor
drains, and floors and walls were washed once daily
with water via a high pressure sprayer to minimize
repeated challenge from bacteria shed through each
animal’s own feces. Cross-contamination was prevented by housing one animal per room, and by having animal caretakers and research personnel change
personal protective equipment (except respirators)
and clothing between rooms. Animal waste was autoclaved in a sewage sterilization plant prior to discharge in the municipal sewage system.
2.3. Experimental design
Six healthy yearling beef cattle, individually housed
in BL-2 isolation rooms, were orally inoculated once
in the feed with 1 × 109 CFU of E. coli O157:H7 (wildtype strain 86-24), and each animal was observed
to consume the entire feed sample. EHEC O157:H7
strain 86-24 is Stx2+, and was originally isolated from
a human patient with bloody diarrhea (Griffin et al.,
1988). After inoculation, cattle were examined once
daily for clinical signs for the duration of the study.
Animal experiments were approved by the UNL Institutional Animal Care and Use Committee, and the
UNL Institutional Biosafety Committee.
2.4. Sample collection and examination
Samples were collected daily from the centers of
fresh fecal pats on the floor for 14 days post-challenge
(DPC), and on alternate days for 28 days thereafter
to quantify levels of fecal shedding of the inoculum
strain. Previous studies have shown the usefulness
of copro-antibody quantification for the assessment
of intestinal immunoglobulins in calves (Heckert et
al., 1991) and other ruminant species (Rehbinder and
Hau, 2006). Therefore, fecal samples from the rectum
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were collected to test for intestinal antibodies, and serum samples from the jugular vein were obtained to
assess the humoral response on 0, 14, 28 and 42 DPC.
Immediately after their collection, serum samples
were stored at −20 °C; whereas fecal samples were
suspended 1:5 (w/v) in sodium acetate buffer (pH 4.5,
10 mM) containing 0.1% (w/v) soybean trypsin inhibitor, 5 mM EDTA, 80 μg/ml of gentamicin, 10 IU/ml
penicillin, and 10 μg/ml of streptomycin (Dréau et al.,
1995). The mixture was centrifuged once at 2500 × g
for 20 min to sediment larger particles and once at
15,000 × g for 30 min. Finally, the supernatant was
collected and stored at −20 °C until the analysis could
be performed.
2.5. Fecal shedding
Fecal samples were obtained via fresh pats on the
floor and immediately processed. Each sample was
quantified by direct plating (DP) on SMAC-CT (sorbitol-MacConkey plates containing 0.5 μg/ml cefixime
and 2.5 μg/ml potassium tellurite) plates and cultured
in enrichment broth (GN-VCC = GN broth containing
8 μg/ml vancomycin, 0.05 μg/ml cefixime and 10 μg/
ml cefsulodin) followed by plating on SMAC-CT to detect levels of shedding that were undetectable by DP.
For enrichment (E) culture, 10 g of feces were incubated in 90 ml of GN-VCC for 6 h at 37 °C. One millilitre of these cultures was subjected to O157 immunomagnetic separation (IMS, Dynal) and 50 μl of the
mixture were spread on SMAC-CT plates. Sorbitolnonfermenting colonies were subcultured on MacConkey and Fluorocult (E. Merck) agars. Colonies that
fermented lactose but not sorbitol, and lacked β-glucuronidase activity [non-fluorescent on Fluorocult,
which contains 4-methylumbelliferyl-β-d glucuronide
(MUG)], were further tested for reactions in triple
sugar iron, indole and methyl red-Voges-Proskauer
media. Indole-positive isolates were subcultured onto
blood agar and tested for E. coli O157 and H7 antigens by latex agglutination test (Remel RIM® E. coli
O157:H7 Latex Test). Isolates giving the expected reactions in the aforementioned tests were thus identified as E. coli O157:H7.
2.6. Antibody response
Isotype-specific (IgA and IgG) fecal and serum antibody titers were determined by an indirect ELISA using a modification of the procedures previously described by Li et al. (2000). E. coli BL21, a λDE3 lysogen
strain containing a pET28 expression vector, kindly
provided by Dr. B. Brett Finlay (University of Brit-
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ish Columbia), was the source of E. coli O157:H7 protein antigens. This strain expresses histidine-tagged
eae, tir-CesT, espB or espA genes. CesT is the chaperone protein for Tir, which is required for Tir protein
stability (Abe et al., 1999). The region of the eae gene
cloned into the recombinant intimin construct encodes
the 280-carboxyl-terminal amino acids, specific for the
γ-intimin subtype. Purified proteins were obtained using commercially available Ni2+ affinity columns (Novagen His-Bind Kit, EMD Biosciences-Merck). The
source of E. coli O157 LPS was E. coli O157:H7 strain
86-24, obtained by phenol–water extraction and purified by standard methods (Jann, 1985). Individual
wells of microtiter plates were coated with 100 μl of
Tir (100 ng), intimin (180 ng), EspA (160 ng), EspB
(240 ng) (Li et al., 2000), or O157 LPS (150 ng) in a
0.1 M carbonate buffer (pH 9.6), and incubated overnight at 4 °C. After two washes with PBS, wells were
blocked with 1% BSA, heat-treated at 60 °C, in carbonate buffer. Serum samples were serial twofold diluted in PBS and tested at a starting dilution of 1:100
for IgG or 1:20 for IgA. Fecal samples were also serially diluted in PBS, but the initial dilution tested for
both IgG and IgA antibodies was the undiluted processed sample (1:5 in sodium acetate buffer). Plates
were incubated for 2 h at 37 °C, washed and blocked,
as previously described (Li et al., 2000). One hundred
microlitre of a 1:10,000 PBS dilution of horseradish
peroxidase-conjugated goat anti-bovine IgG (H + L,
affinity purified; Jackson Immunoresearch Laboratories) or 1:5000 PBS dilution of horseradish peroxidase-conjugated rabbit anti-bovine IgA (Bethyl Laboratories, Inc.) was added to each well. Plates were
incubated for 1 h at 37 °C, and washed three times
with PBS. Orthophenylenediamine plus hydrogen
peroxide was used as the substrate for the reaction.
ELISAs were read at a wavelength of 490 nm. Three
duplicate determinations were performed for each
sample. The antibody titer was the highest dilution
having an absorbance (mean − 2 ≥ S.D.) greater than
the negative control (mean + S.D.), which included all
reagents except the serum.
2.7. Statistical analysis
The level and length of fecal shedding were determined. The mean magnitude and duration of fecal
shedding were estimated for the first 14 DPC. After 14 DPC, shedding was evaluated on alternate
days for 28 days. Two means, each calculated from
seven observation points over a 14-day sampling period were determined. The mean magnitude of fecal
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shedding was the geometric mean (GM) expressed as
log10 CFU/g (wet weight) of feces. The mean duration
of fecal shedding based on DP or E-IMS, expressed as
the percent of days in which E. coli O157:H7 was detected was determined. GM antibody titers were calculated from the highest dilution of each serum sample
in which a detectable immune response was determined ([Li et al., 2000] and [Potter et al., 2004]). To
determine the statistical distribution of the antibody
titers, a normality test was performed by the UNIVARIATE procedure of SAS (1999), using the Shapiro–Wilks W statistic. Because antibody titers were
not normally distributed, they were analyzed by the
non-parametric Kruskal–Wallis test, followed by the
Tukey–Kramer test for comparison of means (Dowdy
and Wearden, 1991) by SAS (1999). The association
between fecal shedding and serum IgG responses
(pre-existing or post-challenge titers) was assessed
by Spearman’s correlation analysis (Proc CORR, SAS,
1999). A significant difference was declared to exist
when P ≤ 0.05. Least squares means (LSM) and the
S.E.M. are reported, unless otherwise stated.
3. RESULTS
3.1. Animal health
All animals were healthy throughout the experiment,
including the time period after inoculation with E.
coli O157:H7. Although cattle actively shed E. coli
O157:H7, none developed anorexia or diarrhea, and
all maintained or gained weight during the 42-day experimental period.
3.2. Pre-inoculation serum IgG and IgA
antibody titers
Pre-inoculation serum antibody titers to O157 LPS
and E. coli O157:H7 intimin, Tir, EspB and EspA
were determined by indirect ELISA with individual
serum samples taken from 30 healthy adult beef cattle (Figure 1). All animals were IgG-seropositive for
all five antigens, with GM IgG titers to EspB and
O157 LPS antigens significantly higher (P < 0.05)
than those detected for Tir, intimin and EspA. Cattle were also seropositive for IgA antibodies to each
antigen; however, as expected, the titers were much
lower than those detected for serum IgG. The serum
IgA titer to EspB was significantly higher (P < 0.05)
than that to all other antigens. Although the serum
IgA titer to Tir was significantly lower (P < 0.05) than
that to EspA, the former was not significantly different (P > 0.05) from IgA titers to O157 LPS or intimin.
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Figure 1. Pre-existing serum IgG and IgA titers to O157 LPS and locus of enterocyte effacement (A/E) proteins in adult cattle. LSM and S.E.M. are presented. Bars (IgG) or dashes (IgA) with the same letters are not significantly different (P > 0.05),
n = 30. Samples were tested at a starting dilution of 1:100 for IgG or 1:20 for IgA followed by serial twofold dilutions thereafter. Serological titers are expressed as median values of the highest positive dilution of sera.

3.3. Magnitude and duration of fecal shedding
after experimental inoculation with E. coli
O157:H7
There was a wide variation in the magnitude
(log10 CFU/g) and duration (percent of days positive)
of fecal shedding among animals. The challenge organism was shed in the feces at relatively high levels
(GM, 412 CFU/g) over the first 14 DPC. From 15 to
42 DPC the magnitude of shedding decreased ~98%
compared to 1–14 DPC; however, cattle continued to
shed the microorganism at low levels, indicating that
they were colonized, and that pre-existing serum antibodies to O157 LPS and A/E proteins did not prevent
cattle from intestinal colonization by E. coli O157:H7.
Based on the DP and E-IMS procedures, the percent of positive days (mean ± S.D.) of detection of
E. coli O157:H7 in feces, as a measure of duration
of shedding for the first 14 DPC, was 57 ± 23% and
81 ± 34%, respectively. Thus, as indicated by the duration of fecal shedding, E-IMS procedure was consistently more sensitive for the recovery of E. coli O157:
H7 from feces than DP culture. As determined by DP,
fecal shedding of E. coli O157:H7, on the average, became undetectable at 24 DPC (range of 8–42 days),
whereas by E-IMS procedure a complete decline in fecal shedding was established at an average of 27 DPC
(range of 8–42 days).
3.4. Serum and fecal antibody titers following
experimental inoculation with E. coli O157:H7
Serum and fecal antibody titers to O157 LPS and E.
coli O157:H7 intimin, EspA, EspB and Tir were deter-

mined at 0, 14, 28 and 42 DPC, and compared with the
magnitude of fecal shedding in orally inoculated cattle.
There was no relationship between pre-existing titer to
any antigen and the level of shedding after inoculation
(P > 0.4; Figure 2). However, infection resulted in an
increase in the serum IgG titers to LEE-encoded proteins above that of the pre-inoculation levels (Figure 3).
Coincident with the highest level of fecal shedding at
14 DPC, the GM titers to intimin, Tir and EspB were
significantly increased (P < 0.05), whereas a significant
increase (P < 0.05) in the anti-EspA serum response
was detected later, at 28 DPC. At 14 DPC, cattle also
had a 1.7-fold increase in their serum IgG titers to
O157 LPS; however, this difference was not significant
(P > 0.05). By 42 DPC, the titers to all antigens, except
EspB, were on the decline following the low level of fecal shedding. The serum IgG titers to Tir, intimin and
O157 LPS (r = 0.98, P < 0.05), but not EspA or EspB
were highly correlated with the level of fecal shedding.
Although not statistically significant (P > 0.05), serum
IgA titers to O157 LPS increased, whereas those to intimin, EspB and Tir decreased by 14 DPC (Figure 4).
Pre- and post-inoculation fecal IgG and IgA antibodies
to LEE-encoded proteins and O157 LPS were not detected (<1:5).
4. DISCUSSION
The major finding of this study was that adult cattle
developed a significant serum IgG antibody response
to E. coli O157:H7 LEE-encoded proteins (Tir, EspA,
EspB and Tir) following infection. At the inoculum
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Figure 2. Influence of pre-existing serum IgG titers to O157 LPS and locus of enterocyte effacement (A/E) proteins on Escherichia coli O157:H7 fecal shedding in orally inoculated adult cattle (n = 6). Serological titers are the highest positive dilution of sera. Fecal shedding is the mean of 14 days. The correlation between these two variables was not statistically significant (P > 0.4).

level we used (1 × 109 CFU), we found that the serum
IgG responses of cattle to O157 LPS, intimin, EspA,
and Tir were short-lived, whereas that to EspB was
greater and more prolonged. It is possible that the responses could have been higher and more pronounced
with a higher inoculum level, since Johnson et al.
(1996) reported that the serum anti-O157 antibody titers were sustained in adult cattle following an inoculation with 1 × 1010 CFU (Cray and Moon, 1995). To
our knowledge, this is the first study to report antibody responses to LEE-encoded proteins in cattle in
response to experimental infection. It is of further importance that the study was conducted in adult cattle,
which are the major source of ground beef.
We inoculated cattle with a level of E. coli O157:
H7 thought to be within the range of a likely natural challenge dose ([Besser et al., 1997], [Besser et al.,

2001] and [Sanderson et al., 1999]). We housed the
cattle individually in BL-2 isolation rooms to minimize repeated exposure and prevent cross-contamination from other cattle (Besser et al., 2001), which allowed us to more accurately ascertain the response to
a known inoculum level. This approach has an advantage over studying the duration of shedding in natural conditions, since it is difficult in the latter situation to determine the actual inoculum level.
The inoculum dose used in our study was sufficient to induce colonization, as evidenced by the
length of fecal shedding, which ranged from 8 to 42
days (mean, 24), and the length of shedding was comparable to that detected in natural infections ([Besser
et al., 1997] and [Khaitsa et al., 2003]). Besser et al.
(1997) reported that the duration of detected fecal excretion of E. coli O157:H7 by naturally infected cat-
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Figure 3. Fecal shedding (□) (log10 colony-forming units/g) vs. serological IgG immune response to intimin, EspA, EspB and
Tir (–) from yearling cattle (n = 6) orally inoculated with E. coli O157:H7 (Wild type 86-24 strain). At day 0 the pre-existing,
field-induced IgG titers are indicated. Serum samples were tested at a starting dilution of 1:100 followed by serial twofold
dilutions thereafter. For each immune response, different letters across the X-axis indicate statistical difference (P < 0.05)
among time points (days of bleeding: 0, 14, 28 and 42). LSM and S.E.M. are presented. Serological titers are expressed as
median values of the highest positive dilution of sera.

tle was <1 month in most cattle tested. Khaitsa et al.
(2003) found that the duration of fecal shedding in
feedlot cattle ranged from 1 to 4.5 weeks, and peaked
during the epidemic phase, which corresponds to
times of higher challenge levels.
In our study, since all cattle tested had pre-existing antibodies that had resulted from natural exposure and they shed for 8–42 days after inoculation,
we interpret that those responses were insufficient
for complete protection. It is possible there was some
effect on reduction of shedding; however, we did not
find any significant relationship between pre-existing titer to any antigen and shedding. Our group
and other researchers have found that young calves
([Naylor et al., 2007] and [Sanderson et al., 1999])
and adult cattle ([Cray and Moon, 1995] and [Khaitsa
et al., 2003]) shed less following repeated experimental inoculations, and this suggests that protective immune responses do occur following infection. However, these responses are not completely protective,
as evidenced by repeated infections in natural conditions, and the finding that the duration of fecal shedding in these conditions does not differ significantly
between the first and second infections or first and
third infections (Khaitsa et al., 2003). Other investigators have reported that serum anti-O157 responses
were not correlated with elimination of infection or
protection against reinfection with the same strain;
however, they did not address the responses to anti-

gens that have been shown to be important for intestinal colonization ([Johnson et al., 1996] and [Wray et
al., 2000]).
The predominance of IgG over IgA antibodies
found in this experiment is consistent with the concentrations of these immunoglobulin classes in serum of adult cattle ([Mach and Pahud, 1971] and
[Lascelles et al., 1986]). Although cattle are known to
mount a significant serum IgG titer to O157 LPS in
response to infection with E. coli O157:H7 ([Johnson
et al., 1996] and [Wray et al., 2000]), we cannot rule
out the possibility of serologic cross-reactivity with
certain other Gram-negative bacteria as a contributing factor for the pre-existing anti-O157 LPS IgG titers detected in this study ([Chart and Jenkins, 1999],
[Laegreid et al., 1998] and [Nielsen et al., 2004]).
A recent study demonstrated that 6–8-week-old
calves initially inoculated with an Stx− strain but not
Stx2+ E. coli O157:H7 strain 86-24 developed statistically significant lymphoproliferative responses to
heat-killed Stx2+ E. coli O157:H7 (Hoffman et al.,
2006). In the same study, all calves inoculated with
E. coli O157:H7, regardless of Stx production by the
respective strain, developed antibodies to O157 LPS.
The authors hypothesized that Stxs are immunosuppressive and play a role in promoting STEC colonization in the bovine host, despite the fact that cattle develop humoral immune responses during the course
of infection. Although cattle in the present study were
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Figure 4. Fecal shedding (□) (log10 colony-forming units/g) vs. serological IgA immune response to O157 LPS and locus of
enterocyte effacement proteins (–) from yearling adult cattle (n = 6) orally inoculated with E. coli O157:H7 (Wild type 86-24
strain). Data of shedding are the same as those presented in Figure 3. At day 0 the pre-existing, field-induced IgA titers are
indicated. Serum samples were tested at a 1:20 starting dilution followed by serial twofold dilutions. Statistical differences
were not found among time points (days of bleeding: 0, 14, 28 and 42) for any antigen. LSM and S.E.M. are presented. Serological titers are expressed as median values of the highest positive dilution of sera.

inoculated with the same Stx2+ strain (86-24), we did
not address their lymphoproliferative responses.
Overall, we detected a highly significant, positive
association between the pattern of fecal shedding and
the serum IgG response to Tir, intimin or O157 LPS.
Thus, such high positive correlation (r = 0.98) may explain the failure of these antigens to induce a longlasting serological IgG response following oral inoculation of cattle. In contrast to the serological IgG
titers, the serum IgA titers to Tir, intimin and EspB
decreased (P > 0.05) after oral challenge. Wray et al.
(2000) found that serum IgM but not IgG antibody
titers to O157 LPS in calves decreased after experimental infection. These authors did not study the antibody responses to other antigens, nor those of the
IgA class. However, a very recent publication has reported that young calves developed serum antibody
responses of the IgG and IgA class to O157 and H7,
and the IgA but not IgG titers decreased after colonization following a repeat challenge (Naylor et al.,
2007). Interestingly, in our study, the IgA titers decreased only to factors having a known (Eae, Tir)
or highly probable function in colonization (EspB),
whereas those to O157 increased. Hence, as initially
proposed by Wray et al. (2000) and extended by the
findings of this study and the recent one by Naylor
et al. (2007), the decrease in serum IgM and IgA titers soon after challenge may be evidence of their consumption in response to challenge, through binding to
E. coli O157:H7 and its secreted products.

Mucosal antibodies to various antigens can be detected in the feces of ruminants ([Heckert et al., 1991]
and [Rehbinder and Hau, 2006]), rats (Hau et al., 2001)
and humans (Vetvik et al., 1998). Digestive and bacterial proteases can reduce the rate of recovery of antibodies in the feces ([Grewal et al., 2000] and [Vetvik
et al., 1998]). However, in the present study, copro-antibodies against E. coli O157:H7 antigens were undetectable despite immediate processing and freezer storage of fecal samples, which were attempts to minimize
proteolytic degradation. The lack of detection of coproantibodies in our study is similar to the results of Conlan et al. (1999), who reported a very sporadic detection
of anti-O157 LPS fecal antibodies in mice orally challenged with E. coli O157:H7. In human patients with
enteric disease, the rates of recovery of copro-antibodies are significantly higher in those with active gut inflammation (Ferguson et al., 1995).
In summary, this study has demonstrated that
adult cattle respond serologically to E. coli O157:H7
LEE-encoded type III secreted proteins and intimin
as a result of infection. In general, protective mucosal immune responses are most effectively induced
by mucosal immunization ([Dougan et al., 2000] and
[Neutra and Kozlowski, 2006]), but very little information is currently available concerning the bovine
mucosal immune responses to E. coli O157:H7. More
studies are needed in this regard in order to develop
effective preventive and control strategies for E. coli
O157:H7 in cattle.
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